跳至主要内容
临床试验/NCT04530500
NCT04530500撤回不适用

In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

University of California, Irvine2 个研究点 分布在 1 个国家开始时间: 2020年8月13日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Number of patients deceased

研究概览

简要总结

This research study will evaluate the association of Androgen Receptor (AR) gene expression and COVID-19 disease severity and mortality. The research procedure involves collection of a single saliva sample which will be mailed to the participants by the study team. This saliva will be used in a COVID-19 Androgen Sensitivity Test (CoVAST) which will detect AR gene expression. Eligible participants are males, at least 18 years or older, and have tested positive for COVID-19.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male over the age of 18
  • Laboratory confirmed SARS-CoV-2 infection
  • Able to give verbal informed consent

排除标准

  • Unable to give informed consent
  • Diagnosed with an additional respiratory co-infection
  • XXY males

结局指标

主要结局

Number of patients deceased

时间窗: 28 days

Number of subjects deceased at or before 28 days

次要结局

  • Number of patients discharged(14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Natasha Mesinkovska

Director of Clinical Research

University of California, Irvine

研究点 (2)

Loading locations...

相似试验

COVID-19 In-vitro Diagnostic Test and Androgen... | 临床试验